Ex parte RIBIER et al. - Page 9




          Appeal No. 96-2897                                                          
          Application 08/050,315                                                      
          the claims include within their scope . . . .”  In re Geerdes,              
          491 F.2d 1260, 1262, 180 USPQ 789, 791 (CCPA 1974).                         
               On remand, before the examiner decides anew exactly what               
          subject matter is being claimed, we direct the examiner’s                   
          attention to page 6, line 19, to page 7, line 21, of the                    
          specification.  More specifically, the examiner should compare              
          the appellants’ teachings at page 6, line 19, to page 7, line               
          1, and page 7, lines 2-21, to Devissaguet’s Examples 2, 4, 5,               
          6,                                                                          
          and 7 at columns 5-7 and Devissaguet’s teachings at column 3,               
          lines 19-33.  For example, appellants’ specification teaches                
          that (1) simple triglycerides, triglycerides modified by                    
          oxyethylenation, volatile silicone oils and mineral oils are                
          “nonactive carrier oils” (Spec., p. 7, l. 2-5), and (2) “[t]he              
          active ingredient is preferably an oleophilic active                        
          ingredient which dissolves in oil” (Spec., p. 7, l. 6-7).                   
          However, the specification also teaches (Spec., p. 7, l. 10-                
          21):                                                                        
                    It is possible, according to the invention, to                    
               introduce into the oily phase at least one nonoily active              
               ingredient in a carrier oil and/or in an active oil.                   
               This active ingredient, irrespective of its presentation,              
               may be a humectant such as hyaluronic acid, orotic acid                
               or a lipoprotein, an anti-acne agent, a lipid regulator                
               such as an extract of Centella asiatica or gamma-                      
                                        - 9 -                                         





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007